Crossmark

Improving the prediction of chemotherapy dose-limiting toxicity in colon cancer patients using an AI-CT-based 3D body composition of the entire L1–L5 lumbar spine

Crossref DOI link: https://doi.org/10.1007/s00520-024-09108-8

Published Online: 2024-12-21

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cao, Ke

Yeung, Josephine

Wei, Matthew Y. K.

Choi, Cheuk Shan

Lee, Margaret

Lim, Lincoln J.

Arafat, Yasser

Baird, Paul N.

Yeung, Justin M. C.
License Information

Text and Data Mining valid from 2024-12-21

Version of Record valid from 2024-12-21
More Information

Article History

Received: 21 May 2024

Accepted: 15 December 2024

First Online: 21 December 2024

Declarations

:

: This study was approved by the Ethics Department at the Western Health Office for Research (Project QA2020.24_63907). The protocol followed the tenets of the Declaration of Helsinki and all privacy requirements were met.

: The ethical application approves a waiver of consent.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below